Daniel Hogan, MD
Enriched profileDermatologist, C.W. Bill Young VA Medical Center (Bay Pines VA Healthcare System) · Bay Pines VA Healthcare System
Daniel Hogan is Dermatologist, C.W. Bill Young VA Medical Center (Bay Pines VA Healthcare System) at Bay Pines VA Healthcare System. OpenAlex indexes 207 publications with 5,067 citations (h-index 33); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Daniel Hogan, MD, is Dermatologist, C.W. Bill Young VA Medical Center (Bay Pines VA Healthcare System). The public record shows 207 publications with 5,067 citations (h-index 33), centered on Atopic Dermatitis / Eczema. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 1 companies.
- Most recent indexed publication: 2024 · PloS one
- Top research focus: Atopic Dermatitis / Eczema
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
- Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches
Sponsor: Chattem, Inc.
Industry payments
Updated 27 Aug 2026
1 company reported payments to CMS in program years 2022–2022. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20221 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Azole Antifungal100%Ketoconazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedicine.medscape.com ↗
- Board Certified
American Board of Dermatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mqa-internet.doh.state.fl.us ↗
Editorial & leadership roles
journal and society appointments- Fellow
American Academy of Dermatology (FAAD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Member
Alpha Omega Alpha; American Academy of Dermatology; American Contact Dermatitis Society; Canadian Dermatology Association
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedicine.medscape.com ↗ - Contributing author
eMedicine/Medscape dermatology clinical reference articles (e.g., Pressure Urticaria, Sebaceous Hyperplasia, Corns/Clavus, Malassezia Folliculitis)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedicine.medscape.com ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor of Internal Medicine (Dermatology)
Nova Southeastern University College of Osteopathic Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedicine.medscape.com ↗ - Investigator
Hill Top Research, Florida Research Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedicine.medscape.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.